|
CA3115394A1
|
|
Compositions and methods for preventing allergies
|
|
US2017183685A1
|
|
Ungulates with Genetically Modified Immune Systems
|
|
CN108473963A
|
|
Multiple transgenic pig for heterograft
|
|
AU2015204349A1
|
|
Use of interfering RNA in the production of transgenic animals
|
|
AU2012205138A1
|
|
Use of interfering RNA in the production of transgenic animals
|
|
AU2012217792A1
|
|
Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
|
|
AU2012200570A1
|
|
Ungulates with genetically modified immune systems
|
|
CA3104704A1
|
|
Multi-transgenic pigs for diabetes treatment
|
|
EP2348827A1
|
|
Immunocompromised ungulates
|
|
AU2008203109A1
|
|
Double nuclear transfer method and results thereof
|
|
AU2008202720A1
|
|
Genetic modification of somatic cells and uses thereof
|
|
CA2617930A1
|
|
Transgenic ungulates expressing ctla4-ig and uses thereof
|
|
CA2958259A1
|
|
Ungulates with genetically modified immune systems
|
|
AU2005203067A1
|
|
Genetic modification of somatic cells and uses thereof
|
|
CN1953657A
|
|
Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase
|
|
AU2005223617A1
|
|
Tissue products from animals lacking functional alpha 1,3 galactosyl transferase
|
|
NZ547388A
|
|
Use of interfering RNA in the production of transgenic animals
|
|
EP2514826A2
|
|
Use of interfering RNA molecules to down regulate the expression of specific genes or family of genes
|
|
AU2003295322A1
|
|
Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
|
|
NZ550899A
|
|
Double nuclear transfer method and the production of a non human animal thereby
|
